Multi High-Throughput Approach for Highly Selective Identification of Vaccine Candidates: the Group A Streptococcus Case

Giuliano Bensi, Marirosa Mora, Giovanna Tuscano, +21

Molecular & Cellular Proteomics

Experimental StrategyAccurate SelectionImmunologyVivo Protection AssaysBacterial Pathogens +15

SslE Elicits Functional Antibodies That Impair In Vitro Mucinase Activity and In Vivo Colonization by Both Intestinal and Extraintestinal Escherichia coli Strains

Barbara Nesta, María Cristina Valeri, Angela Spagnuolo, +20

PLoS Pathogens

Microbial PathogensImmunologyEscherichia ColiAntigen ProcessingInnate Immunity +19

One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A

Francesca Mancini, Elisabetta Monaci, Giuseppe Lofano, +19

PLoS ONE

Microbial PathogensHumoral ResponseImmunologyStaphylococcus AureusImmunodominance +17

Plasminogen- and Fibronectin-binding Protein B Is Involved in the Adherence of Streptococcus pneumoniae to Human Epithelial Cells

Salvatore Papasergi, Manuela Garibaldi, Giovanna Tuscano, +8

Journal of Biological Chemistry

Targeted Amino Acid Substitutions Impair Streptolysin O Toxicity and Group A <i>Streptococcus</i> Virulence

Emiliano Chiarot, Cristina Faralla, Nico Chiappini, +15

mBio

SpyAD, a Moonlighting Protein of Group A Streptococcus Contributing to Bacterial Division and Host Cell Adhesion

Marilena Gallotta, Giovanni Gancitano, Giampiero Pietrocola, +12

Infection and Immunity

Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant women

Monica Fabbrini, Fabio Rigat, Giovanna Tuscano, +11

Journal of Infection

Immune Response to Invasive Group B<i>Streptococcus</i>Disease in Adults

Morven S. Edwards, Marcia A. Rench, C. Daniela Rinaudo, +6

Emerging infectious diseases

VaccinationMedical MicrobiologyPilus IslandMicrobial DiseaseMicrobial Pathogens +9

Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particles

Filippo Carboni, Roberta Cozzi, Giacomo Romagnoli, +23

npj Vaccines